Skip to main content
Contact Us
Subscribe
E-Edition
80°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biotricity Inc
(NQ:
BTCY
)
0.4631
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biotricity Inc
< Previous
1
2
3
4
Next >
Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023
January 17, 2023
Via
ACCESSWIRE
Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth
December 12, 2022
Via
ACCESSWIRE
Biotricity Surpasses $10 Million in Annual Revenue Run Rate
November 21, 2022
Via
ACCESSWIRE
Biotricity Provides Updates on its Operational and Expansion Strategy
November 18, 2022
Via
ACCESSWIRE
Biotricity Signs Distribution Agreement to Expand Access for its Cardiac Monitoring Solutions
November 16, 2022
Via
ACCESSWIRE
Biotricity Reports Financial Results for Fiscal 2023 Second Quarter
November 14, 2022
Via
ACCESSWIRE
Biotricity's Bioheart Named to TIME's List of The Best Inventions of 2022
November 10, 2022
Via
ACCESSWIRE
Biotricity Surpasses 2 billion Recorded and Analyzed Heartbeats for Atrial Fibrillation (AFib)
October 04, 2022
Via
ACCESSWIRE
Biotricity to Host Fiscal 2023 Second Quarter Financial Results on November 14th at 4:30 PM ET
November 01, 2022
Via
ACCESSWIRE
Biotricity Launches Cardiac Disease Management Solution Following 2 Successful Pilots with Oklahoma & Kentucky Clinics
October 26, 2022
Via
ACCESSWIRE
Biotricity CEO, Waqaas Al-Siddiq, to Participate in Panel Discussion on the Evolution of Medical Devices at the American Medical Device Summit on October 19th
October 13, 2022
Via
ACCESSWIRE
Biotricity Wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled Real-Time Monitoring and Predictive Analytics for Stroke due to Chronic Kidney Failure
September 07, 2022
Via
ACCESSWIRE
Biotricity Reports Financial Results for Fiscal 2023 First Quarter
August 15, 2022
Via
ACCESSWIRE
Biotricity to Host Fiscal First Quarter 2023 Financial Results Conference Call on August 15th at 4:30 p.m. ET
August 05, 2022
Via
ACCESSWIRE
Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year
July 14, 2022
Company Reports Record Revenue and Improved Margins
From
Biotricity, Inc.
Via
AccessWire
Exposures
COVID-19
Biotricity to Join Russell Microcap(R) Index
June 23, 2022
REDWOOD CITY, CA / ACCESSWIRE / June 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that the...
From
Biotricity, Inc.
Via
AccessWire
Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th
May 23, 2022
REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is scheduled to present...
From
Biotricity, Inc.
Via
AccessWire
Biotricity Issues Shareholder Update
May 05, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Biotricity, Inc.
Via
AccessWire
Exposures
COVID-19
Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022
March 22, 2022
- Company reports pre-order sales from existing customers of its wireless wearable device for early detection of cardiac arrhythmias REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Biotricity, Inc....
From
Biotricity, Inc.
Via
AccessWire
Exposures
Product Safety
Biotricity Inc. (NASDAQ: BTCY) Featured in Virtual Coverage of the 34th Annual Roth Conference
March 11, 2022
Via
Investor Brand Network
Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022
March 08, 2022
Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and more REDWOOD CITY, CA / ACCESSWIRE / March 8, 2022 / Biotricity, Inc. (NASDAQ:BTCY)...
From
Biotricity, Inc.
Via
AccessWire
Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th
March 04, 2022
- Follows fiscal third quarter earnings that saw revenue up 93% year-over-year and Company's highest-ever quarterly cash position - Biotricity now taking preorders for Biotres, an FDA-cleared,...
From
Biotricity, Inc.
Via
AccessWire
Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device
February 23, 2022
- Announcement follows FDA clearance - Pre-Orders begin on February 23, 2022 with units shipping April 1, 2022 REDWOOD CITY, CA / ACCESSWIRE / February 23, 2022 / Biotricity, Inc. (NASDAQ:BTCY)...
From
Biotricity, Inc.
Via
AccessWire
Exposures
Product Safety
Biotricity Releases Fiscal 2022 Third Quarter Financial Results
February 14, 2022
Management to host investor call on Tuesday February 15th at 4:15 pm ET - 93% YOY Revenue Gains to $1.93 Million - Revenue Outpaces SG&A Increase by 2.2x - Cash Position of $16.8 Million at Quarter End...
From
Biotricity, Inc.
Via
AccessWire
Biotricity to Report Third Quarter Fiscal 2022 Financial Results on February 14, 2022
February 08, 2022
Management to host call on Tuesday, February 15th at 4:15pm ET Sees Calendar-2022 as a breakout year with commercial launch of Bioheart and FDA clearance for Biotres REDWOOD CITY, CA / ACCESSWIRE /...
From
Biotricity, Inc.
Via
AccessWire
Exposures
Product Safety
Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device
January 24, 2022
Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmias The Biotres addresses the $2 Billion-dollar holter market REDWOOD CITY, CA / ACCESSWIRE / January 24, 2022...
From
Biotricity, Inc.
Via
AccessWire
Exposures
Product Safety
Biotricity Expands Distribution of New Bioheart Device on Amazon.com
December 28, 2021
New Heart Monitoring Solution Delivers Personalized Heart Health Insights Directly to Your Smartphone Now Easy to Buy and Use: No Prescription Needed for Advanced Heart and Lifestyle Solution REDWOOD...
From
Biotricity, Inc.
Via
AccessWire
Biotricity Completes $12 Million Non-Dilutive Debt Financing
December 27, 2021
Capital infusion to finance inventory and annual recurring revenue subscriptions replaces expiring debt with more favorable terms 5-year term deal strengthens balance sheet, positions company for...
From
Biotricity, Inc.
Via
AccessWire
Biotricity, a Leader in Remote Cardiac Health Monitoring Solutions, Issues Company Roadmap in 2021 Shareholder Letter
December 07, 2021
The Company believes that it is "well-positioned for 2022." Letter highlights milestones, products roadmap, growth strategy and 2022 goals REDWOOD CITY, CA / ACCESSWIRE / December 7, 2021 / Biotricity,...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Delivers Bioheart, A Groundbreaking Consumer Heart Monitor
November 10, 2021
From
Biotricity, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.